Integrated Quantitative Investments’s Axcelis ACLS Stock Holding History

Integrated Quantitative Investments’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.34M	Buy	+17,649	New	+$2.62M	0.55%	28

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Integrated Quantitative Investments's ACLS Position: Q2 2026 in Review

Integrated Quantitative Investments opened a new position in Axcelis (ACLS) in Q2 2026: 17,649 shares worth $3.34M. The stake represents 0.55% of the portfolio and ranks #28 among its holdings.

439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

Integrated Quantitative Investments held 17,649 shares of Axcelis worth $3.34M as of Q2 2026.
Axcelis was a new Integrated Quantitative Investments position in Q2 2026.
Axcelis made up 0.55% of Integrated Quantitative Investments's portfolio in Q2 2026, its #28 holding.
439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.